Pyxis Oncology (PYXS) Assets Average (2021 - 2025)

Pyxis Oncology (PYXS) has 5 years of Assets Average data on file, last reported at $98.6 million in Q4 2025.

• Assets Average for Q4 2025 came in at $98.6 million, down 44.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.6 million (down 44.08% YoY), and the FY2025 annual result was $124.4 million, down 24.84% from the prior year.
• Assets Average fell to $98.6 million in Q4 2025 per PYXS's latest filing, from $114.4 million in the prior quarter.
• Over five years, Assets Average peaked at $266.4 million in Q1 2022 and troughed at $98.6 million in Q4 2025.
• A 5-year average of $187.7 million and a median of $197.0 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average rose 19.71% in 2024, then sank 44.08% in 2025.
• A 5-year view of Assets Average shows it stood at $209.8 million in 2021, then gained by 3.76% to $217.6 million in 2022, then decreased by 17.2% to $180.2 million in 2023, then declined by 2.2% to $176.2 million in 2024, then slumped by 44.08% to $98.6 million in 2025.
• Business Quant data shows PYXS's Assets Average at $98.6 million in Q4 2025, $114.4 million in Q3 2025, and $129.5 million in Q2 2025.